Thermo fisher scientific selected to support national institute of health's blueprint medtech program

Ilmington, n.c.--(business wire)--the ppd clinical research business of thermo fisher scientific inc., the world leader in serving science, has been awarded a five-year contract to provide regulatory affairs support and related services for the blueprint medtech (bpmt) program, a new multi-institute/center initiative at the national institutes of health (nih) supporting development of translational neurological devices. the bpmt program is a new nih incubator with a collaborative reach across 11 nih institutes, whose goal is to accelerate patient access to safe, effective, cutting-edge medical devices to diagnose and/or treat disorders of the nervous system. during each year of the contract, the bpmt incubator aims to support the development of multiple novel technologies from pharmaceutical, biotechnology and device companies.
TMO Ratings Summary
TMO Quant Ranking